FDA Review posts the Federal Register notices for the week ending 10/4/2019.
FDA Review posts product approval summaries for the week ending 10/4/2019.
Federal Register notice: FDA announces an 11/13 Endocrinologic and Metabolic Drugs Advisory Committee meeting to review a Boehringer Ingelheim supplem...
As part of FDAs Safe Use Initiative, CDER director Janet Woodcock announces a funding opportunity for individuals and organizations to conduct further...
FDA updates a consumer alert to warn against using vaping products containing THC as the latest number of reported cases and deaths associated with va...
FDA accepts for review a DBV Technologies BLA for its investigational Viaskin peanut immunotherapy for treating peanut-allergic children ages four to ...
President Trump claims that the pharmaceutical industry is secretly plotting the demise of his presidency and supporting the current impeachment inqui...
Federal Register notice: FDA corrects a notice that appeared in 8/20 Federal Register announcing a Fit for Use Pilot Program Invitation for the Clinic...